My watch list
my.bionity.com  
Login  
MARKET STUDIES

Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Ra ...

GBI Research’s report, “Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates ...

Riociguat (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020

Introduction GlobalData’s pharmaceuticals report, “Riociguat (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Riocigu ...

Healthcare Logistics Spending in Japan to 2014

Introduction Healthcare Logistics Spending in Japan to 2014 assesses the prospects for logistics in healthcare industry. It provides information o ...

Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Mana ...

Introduction GlobalData’s new report, “Argentina Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, ...

Neonatal Respiratory Distress Syndrome - Pipeline Review, Q2 2011

Introduction Global Markets Direct’s, 'Neonatal Respiratory Distress Syndrome - Pipeline Review, Q2 2011', provides an overview of the Neonatal R ...

Current market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 201 ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Psoriasis. It includes an overview of the tri ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also involved in providing various health care services. The company through its wholly owned subsidiary, Ceres Living, produces and sells the AI ... more

China Chinese Prepared Medicines Mfg. Industry Profile

Through a comparative analysis on the development of Chinese prepared medicines mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key data and concise analyses on the Chinese prepared medicines mfg. industry in China, a list of ma ... more

Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018

Introduction ”Chile ENT Devices Investment Opportunities, Analysis and Forecasts to 2018”, a new report by Global Markets Direct, provides key market data on the Chile ENT Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment ... more

News on market trends
  • Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)

    For the sixth consecutive year, Abbott has been named the leading company in its industry by the Dow Jones Sustainability Index (DJSI). Abbott is one of the 60 companies recognized for leading their respective global industries. The DJSI designation recognizes companies for responsible and sustainab more

  • Bachem to expand in asian markets

    Bachem announces the establishment of Bachem Japan K.K., a subsidiary in Tokyo, Japan. This new local presence in Asia will strengthen project and customer support and drive further business growth in the Asian market."This is an exciting step for Bachem", comments Dr. Anne-Kathrin Stoller, Chief Ma more

  • Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

    Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to accelera more

  • Recipharm invests in Brexit preparations

    Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. With less than a year until the UK exits the European Union (EU), the Sweden headquartered global CDMO is focused on managing the transition with minimal impact to its operations and custome more

  • Gerresheimer expands production of pharmaceutical plastic packaging in Brazil

    Gerresheimer, the leading manufacturer of specialist packaging for drugs, is further expanding its strong presence on the South American market. The new Gerresheimer Anápolis plant has commenced production in the Brazilian state of Goiás in order to secure and support the continued strong growth.  " more

  • Eurofins acquires German pharma quality service company

    Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the next few more

  • DKSH and Bruker AXS sign distribution agreement for Asia Pacific

    DKSH Business Unit Technology, a leading Market Expansion Services provider for technology companies seeking to grow their business in Asia, and Bruker AXS, a leading provider of Analytical X-ray Solutions, have signed a multi-product line distribution agreement for South Korea, Australia, New Zeala more

  • Sanofi to invest €350 million in Canadian vaccine facility

    Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public health a more

  • Lonza opens world's largest cell and gene therapy facility

    Lonza today is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next era in medicine – and with the mission of enabling them to deliver these types of treatments to patients aro more

  • Merck and Three Partners Start ExploreBio

    Merck announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. For this purpose the strategic corporate venture capital arm of Merck has partnered with Arkin Holdings, Pontifax and WuXi AppTec to create t more

New market studies

Turkey Pharmaceuticals and Healthcare Report Q2 2012

BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November ... more

Psoriasis Global Clinical Trials Review, H1, 2012

Introduction GlobalData's clinical trial report, “Psoriasis Global Clinical Trials Review, H1, 2012" provides data on the Psoriasis clinical trial scenari ... more

Promethean Corporation - Strategic SWOT Analysis Review

Promethean Corp. (Promethean) is a New York based Health Care company. The company develops, manufactures and distributes its own products and is also invol ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE